RecruitingEmphysema

STRIVE Post-Market Registry Study

Eligible age

18+ yrs

Accepts

All genders

Locations

11 states

Healthy volunteers

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

This is a single-arm, prospective, multi-center, Registry study to evaluate the long-term safety and effectiveness of the Spiration Valve System (SVS) for the treatment of severe emphysema in a post-market setting.

Sponsor: Olympus Corporation of the Americas

You may qualify if…

✓ 1. Adult patients with shortness of breath and hyperinflation associated with severe emphysema and evidence of low collateral ventilation.
✓ 2. Subjects must understand and voluntarily sign an informed consent form.

You may not qualify if…

✕ 1. Subjects who are not appropriate for SVS therapy based upon the US FDA-approved IFU requirements.
✕ 2. Subjects who were withdrawn from this study for any reason will not be allowed to re-enroll.
✕ 3. Subjects who have incomplete screening or baseline data.